ArticlePharmacoEconomics2004

From randomised clinical trials to clinical practice : a pragmatic cost-effectiveness analysis of Paclitaxel in first-line therapy for advanced ovarian cancer.

Samuel Limat et al.PubMed ↗Publisher ↗

No numbers read from the abstract.